Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2026)
Maxcyte (MXCT) posted quarterly Other Non-Current Liabilities of $262000.0 for Q1 2026, down 2.96% year-over-year from $270000.0 in Q1 2025, and little changed quarter-over-quarter from $263000.0 in Q4 2025.
Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Other Non-Current Liabilities for 7 consecutive years, with $262000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 2.96% year-over-year to $262000.0; the TTM figure through Mar 2026 stood at $262000.0 (down 2.96% YoY), while the FY2025 annual figure was $263000.0, down 4.01% from the prior year.
- Other Non-Current Liabilities steadied at $262000.0 in Q1 2026 per MXCT's latest filing, from $263000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.3 million in Q4 2022 and bottomed at $25000.0 in Q2 2025.
- Historically, Other Non-Current Liabilities has averaged $535618.8 across 5 years, with a median of $281000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities jumped 232.93% — and 2025, when it slumped 91.94%.
- Maxcyte's Other Non-Current Liabilities stood at $1.3 million in 2022, then slumped by 78.56% to $283000.0 in 2023, then fell by 3.18% to $274000.0 in 2024, then dropped by 4.01% to $263000.0 in 2025, then decreased by 0.38% to $262000.0 in 2026.
- Business Quant data shows MXCT's Other Non-Current Liabilities at $262000.0 in Q1 2026, $263000.0 in Q4 2025, and $227000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Maxcyte | 146.35 Mn | 146.35 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 302,000.00 |
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 263,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | 277,000.00 |
| Jun 30, 2024 | 310,000.00 |
| Mar 31, 2024 | 279,000.00 |
| Dec 31, 2023 | 283,000.00 |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 451,100.00 |
| Dec 31, 2021 | 450,200.00 |
| Sep 30, 2021 | 496,600.00 |
| Jun 30, 2021 | 1.19 Mn |